VAF and CN for truncal and private PAMs for WGS of A32 cell line T2.

VAF and CN for truncal and private PAMs for WGS of A32 cell line T2.

<p>VAF and CN for truncal and private PAMs for WGS of A32 cell line T2.</p>

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Kirsten Bowland (15162758) (author)
مؤلفون آخرون: Jiaying Lai (17793078) (author), Alyza Skaist (6741407) (author), Yan Zhang (8098) (author), Selina Shiqing K. Teh (15162749) (author), Nicholas J. Roberts (2841527) (author), Elizabeth Thompson (2136988) (author), Sarah J. Wheelan (14926715) (author), Ralph H. Hruban (265335) (author), Rachel Karchin (61264) (author), Matthew H. Bailey (15147087) (author), Christine A. Iacobuzio-Donahue (213444) (author), James R. Eshleman (14989454) (author)
منشور في: 2024
الموضوعات:
Cell Biology
Genetics
Molecular Biology
Pharmacology
Biotechnology
Evolutionary Biology
Marine Biology
Cancer
Infectious Diseases
year survival rates
varying success rates
specific &# 8220
protospacer adjacent motif
people worldwide annually
ngg &# 8221
current therapeutic regimens
represent genetic vulnerabilities
private loh ),
normal aging prior
form novel tumor
matched primary tumor
cas9 pam targets
predict pam loss
xlink "> regions
xlink ">
primary tumor
pam targets
novel way
genetic instability
bioinformatic tumor
primary carcinomas
universally conserved
truncal loh
surgical resection
strongly retained
related deaths
regions may
pancreatic adenocarcinomas
pams occurring
pams located
normal subtraction
metastatic tissue
metastatic samples
metastatic disease
leading cause
individual cells
identified rules
heterozygous regions
genomic stability
genetically targeted
depth capture
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة